Sino Biopharmaceutical Limited Explained

Sino Biopharmaceutical
Type:listed
Foundation:2000
Location Country:People's Republic of China
Key People:Chairwoman of the Board

Ms. Tse, Theresa Y Y
CEO: Mr. Tse, Eric S Y[1] [2]

Area Served:People's Republic of China
Industry:Pharmaceutical
Parent:Charoen Pokphand Group
Homepage:Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited (|Hang Seng Index component), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.

Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.[3]

Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products.[4]

References

  1. Web site: Sino Biopharmaceutical Limited: Profile . 2024-07-29 . Ms. Y. Y. Tse - Exec. Chairman... Mr. Eric S. Y. Tse - CEO & Exec. Director.
  2. Web site: Sino Biopharmaceutical Limited 1177.HK: Leadership . . 2024-07-29 . Y. Y. Tse - Executive Chairwoman of the Board, S. Y. Tse - Chief Executive Officer, Executive Director.
  3. Web site: Sino Biopharmaceutical Company Overview & News . . https://web.archive.org/web/20230523105608/https://www.forbes.com/companies/sino-biopharmaceutical/ . 2023-05-23 . live .
  4. https://markets.ft.com/data/equities/tearsheet/profile?s=1177:HKG About the company

External links